Post-COVID-19 Syndrome
Journal of Pharmaceutical Negative Results · 01.01.2023
DOI: 10.13140/rg.2.2.28865.53603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Negative Results, erschienen am 01.01.2023. Verfasst von Rajput und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Around 117 million people have had COVID-19 diagnoses globally as of March 2021, and more than 2.6 million havedied as a result (1). The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 is aheterogeneous virus with a wide range of symptoms, from asymptomatic to lethal conditions (2–7). One of the mostprevalent symptoms of SARS-CoV-2 is interstitial pneumonia, which can be made worse by acute respiratory distresssyndrome (ARDS), a condition with a high fatality rate, especially in elderly persons with several coexisting conditions(2, 3). As the COVID-19 pandemic continues, many more symptoms have been reported, including lymphopenia andelevated inflammatory markers (e.g., erythrocyte sedimentation rate, C-reactive protein, ferritin, tumor necrosis factor-,IL-1, and IL-6) as well as symptoms like fever, dry cough, shortness of breath, fatigue, myalgias, nausea/vomiting ordiarrhea, headache, weakness, rhinorrhea, and (2, 3). Impaired heart, brain, lung, liver, kidney, and coagulation systemfunctions are some other severe and life-threatening COVID-19 consequences (4–7).
Schlagwörter
Zitieren
APA
Rajput, Manju, Gupta, Shikha, Katoch, Neha, Natasha, Reinai, T., Rajeev, Kumar, Mittal, Kumari, Saxena, M. M., Sharma, M. S., & Chaudhary, L. (2023). Post-COVID-19 Syndrome. Journal of Pharmaceutical Negative Results. https://doi.org/10.13140/rg.2.2.28865.53603
Vancouver
Rajput, Manju, Gupta, Shikha, Katoch, Neha, et al. Post-COVID-19 Syndrome. Journal of Pharmaceutical Negative Results. 2023. doi:10.13140/rg.2.2.28865.53603
BibTeX
@article{Rajput2023,
author = {Rajput and Manju and Gupta and Shikha and Katoch and Neha and Natasha and Reinai, Thiaba and Rajeev and Kumar and Mittal and Kumari and Saxena, Ms Money and Sharma, Ms Shivani and Chaudhary, Liji},
title = {Post-COVID-19 Syndrome},
journal = {Journal of Pharmaceutical Negative Results},
year = {2023},
doi = {10.13140/rg.2.2.28865.53603}
}
EUVIMED